Literature DB >> 2751157

Neurogenic inflammation in the airways. I. Neurogenic stimulation induces plasma protein extravasation into the rat airway lumen.

M L Kowalski1, A Didier, M A Kaliner.   

Abstract

Activation of sensory nerves in rodent airways results in microvascular permeability and edema formation, presumably due to release of vasoactive neuropeptides from the nerve endings. We examined the possibility that neurogenic stimulation may also induce movement of plasma proteins into the airway lumen. Neurogenic plasma protein extravasation (PPE) was induced in Sprague-Dawley rats by electrical stimulation of both vagal nerves (EVS) at 10 V, 5 ms, 20 Hz. After 90 s of EVS, histologic examination showed Monastral blue B, a macromolecular tracer, extravasated within the endothelium of vessels in the subepithelial layer of the tracheobronchial mucosa. In animals given 125I-labeled albumin intravenously, PPE was quantitated as microliters of plasma deposited into the airways, lung, and tracheobronchial (TB) and bronchoalveolar (BA) lavages. One minute of EVS induced an immediate increase in PPE in the tracheal (+117%) and bronchial wall (+125%) but not in the peripheral lung. There was a concomitant increase in the 125I-labeled albumin recovered from both TB fluid (net increase, 1.29 microliter of plasma = +259%) and BA fluid (net increase, 2.79 microliters of plasma = +107%). In addition, both total protein and endogenous albumin concentrations in TB fluid also increased after EVS. The albumin/total protein ratio (the albumin percentage) in TB lavages was also significantly increased (1.4 x, 1.7 x, and 2.5 x in three separate experiments, respectively), indicating the vascular origin of the increased luminal proteins. Neither cholinergic (atropine) nor adrenergic blockade (phentolamine + propranolol) influenced EVS-induced PPE into the airway walls or movement of radiolabeled albumin into the airway lumen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751157     DOI: 10.1164/ajrccm/140.1.101

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage.

Authors:  Alexander Kopelnik; Landis Fisher; Jacob C Miss; Nader Banki; Poyee Tung; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan Zaroff
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Isolated Pulmonary Edema without Myocardial Stunning in Brainstem Strokes.

Authors:  John C Probasco; Tiffany Chang; David Victor; Paul Nyquist
Journal:  J Neurol Transl Neurosci       Date:  2014

3.  Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD.

Authors:  Mark A Birrell; Natascia Crispino; David J Hele; Hema J Patel; Magdi H Yacoub; Peter J Barnes; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

4.  A change of position for neurogenic pulmonary edema.

Authors:  Scott A Marshall; Paul Nyquist
Journal:  Neurocrit Care       Date:  2008-11-15       Impact factor: 3.210

5.  Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat.

Authors:  D M McDonald; T R Schoeb; J R Lindsey
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage: a randomized experimental study in pigs.

Authors:  Jan Florian Heuer; Paolo Pelosi; Peter Hermann; Christina Perske; Thomas A Crozier; Wolfgang Brück; Michael Quintel
Journal:  Intensive Care Med       Date:  2011-05-05       Impact factor: 17.440

7.  Exogenous interleukin-6, interleukin-13, and interferon-γ provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice.

Authors:  Szu-Wei Huang; Yi-Ping Lee; Yu-Ting Hung; Chun-Hung Lin; Jih-Ing Chuang; Huan-Yao Lei; Ih-Jen Su; Chun-Keung Yu
Journal:  Respir Res       Date:  2011-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.